Sign in

CIK 0001709941

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

BioAge Labs, Inc.

Sign in to watch
Ticker
BIOA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474721157
Phone
+1 510-806-1445
Business address
5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-10 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2025-06-05 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2024-09-27 HEALY JAMES Director Conversion +1,638,236 1,638,236
2024-09-27 HEALY JAMES Director Purchase +588,888 $18.00 $10.6M 2,227,124
2024-09-27 HEALY JAMES Director Purchase +11,113 $18.00 $200K 11,113
2024-09-27 HEALY JAMES Director Purchase +18,353 $18.00 $330K 18,353
2024-09-27 HEALY JAMES Director Purchase +21,814 $18.00 $393K 21,814
2024-09-27 HEALY JAMES Director Purchase +26,497 $18.00 $477K 26,497
2024-09-27 HEALY JAMES Director Conversion · Series D Preferred Stock −7,310,796 0
2024-09-25 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +15,000 15,000

Page 1 of 1 · 10 trades